...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Effects of analytic variations in creatinine measurements on the classification of renal disease using estimated glomerular filtration rate (eGFR).
【24h】

Effects of analytic variations in creatinine measurements on the classification of renal disease using estimated glomerular filtration rate (eGFR).

机译:使用估计的肾小球滤过率(eGFR)进行的肌酐测量分析变化对肾脏疾病分类的影响。

获取原文
获取原文并翻译 | 示例

摘要

Background: This study uses the Isotope Dilution Mass Spectrometer-Traceable Modification of Diet in Renal Disease (MDRD) equation to evaluate the effects of analytic variation of serum creatinine on estimated glomerular filtration rate (eGFR). The equation was inverted to provide critical creatinine levels corresponding to eGFRs equal to 15, 30, and 60 mL/min/1.73 m(2). Methods: eGFRs were calculated for two populations of patients representing clinic outpatients and hospitalized inpatients. Simulation studies evaluated the effects of analytic bias for these populations. Differences between creatinine tests ordered on consecutive blood draws were analyzed for within-subject eGFR variation. Finally, propagation of error techniques established the relationship between creatinine imprecision and eGFR imprecision. Results: eGFR of 60 mL/min/1.73 m(2) corresponds to creatinine levels of 80-156 mumol/L. A 20-mumol/L negative shift of creatinine approximately doubles the percentage of patients classified in various stages of decreased renal function, whereas a positive shift approximately halves the percentage. The central 95% limits for within-subject variation of eGFR are 33% for outpatients, 38% for inpatients and 40% across the groups. eGFR imprecision is approximately 15%-20% higher than creatinine imprecision. Conclusions: Small analytic changes in serum creatinine create major shifts in the distributions of eGFR, which can cause large differences in the classification of patients. The within-subject variations in eGFR over time, especially between hospital and clinic measurements, can be large. Therefore, tight control of laboratory analysis is important. Clin Chem Lab Med 2007;45:737-41.
机译:背景:本研究使用同位素稀释质谱仪-肾脏疾病饮食中可追溯的饮食修改(MDRD)方程来评估血清肌酐分析变化对估计的肾小球滤过率(eGFR)的影响。将该公式倒置以提供与eGFR相等的临界肌酐水平,eGFR等于15、30和60 mL / min / 1.73 m(2)。方法:计算代表门诊和住院患者的两个患者群的eGFR。模拟研究评估了这些人群的分析偏见的影响。分析了连续抽血中订购的肌酐测试之间的差异,以评估受试者体内eGFR的变化。最后,误差技术的传播建立了肌酐不精密度和eGFR不精密度之间的关系。结果:eGFR为60 mL / min / 1.73 m(2)对应于肌酐水平为80-156 mumol / L。肌酐的20-mol / L负位移会使处于肾功能降低各个阶段的患者比例增加一倍,而正位移会将该比例降低一半。门诊患者eGFR变异的中心95%限制为门诊患者33%,住院患者38%和各组40%。 eGFR不精确度比肌酐不精确度高约15%-20%。结论:血清肌酐的微小分析变化导致eGFR分布发生重大变化,这可能导致患者分类大相径庭。 eGFR随时间推移的受试者内部变化可能很大,尤其是在医院和诊所之间。因此,严格控制实验室分析很重要。 Clin Chem Lab Med 2007; 45:737-41。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号